ResMed Inc.
Market cap $28.3B
$195.27
RMD
$195.27
+1.76% today
Buy with €1M virtual cash · No real money
ResMed Inc. (RMD) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates RMD a Hold, with the stock down 29% over the past year. You can practice trading RMD risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$28.3B
Volume
1.0M
52-wk High
$293.81
52-wk Low
$180.27
Day High
$197.60
Day Low
$194.23
P/E (TTM)
18.83
Revenue (TTM)
$5.5B
EPS (TTM)
$10.37
Performance
1M
-0.6%
6M
-23.5%
1Y
-28.6%
Invest signal · RMD
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
RMD overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +0.6%Revenue
$1BEPS (diluted)
$2.74 per shareLatest RMD news
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Benzinga · Jun 3
9 Stocks That Could Defy the ’Sell in May and Go Away’ Trend This Time
Investing.com · May 5
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion
GlobeNewswire Inc. · Apr 29
Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight
GlobeNewswire Inc. · Apr 22
3 Reasons Not to Sleep on ResMed Stock
The Motley Fool · Mar 10
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia.
Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Employees
10,600
30-Day Win Rate · RMD
12 days
11 days
Last 23 sessions
How to practice trading RMD
- 1
Use the RMD buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top RMD traders on Invest
Full leaderboardFrequently asked questions
Is RMD a good stock to buy right now?
As of July 27, 2026, Invest's signal rates RMD a Hold, based on its price trend, valuation, and fundamentals (P/E around 18.8), with the stock down 29% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading RMD risk-free first.
What is ResMed Inc.'s (RMD) market cap?
ResMed Inc. has a market capitalization of approximately $28.3B, on trailing-twelve-month revenue of about $5.5B.
How has RMD stock performed?
RMD is down 29% over the past year and down 24% over six months. Its 52-week range runs roughly from $180.27 to $293.81. Past performance doesn't predict future results.
How can I practice trading RMD for free?
On Invest you get €1,000,000 in virtual cash and can buy RMD at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare RMD with peers